GlassScriptPhysician profile
Noah J Jones
NPI 1326178815
$237,521.45
in general payments reported to CMS, 2019-2025
18 companies · $586 in 2025
The $586 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110K · 2020: $74K · 2021: $37K · 2022: $11K · 2023: $1,127 · 2024: $4,950 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,045 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250 · Travel and Lodging: $1,086 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,045.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
| Travel and Lodging | $1,086.29 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $102,952.32 | 2019-2025 | Mitraclip, Portico, Navitor |
| Edwards Lifesciences Corporation | $44,362.31 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Ekos Corporation | $33,943.99 | 2019 | |
| Cardinal Health 200 LLC | $29,075.00 | 2019-2021 | |
| Boston Scientific Corporation | $17,131.08 | 2019-2024 | Watchman Flx |
| Cordis US Corp. | $6,000.00 | 2021-2022 | |
| Medtronic Vascular, INC. | $1,875.00 | 2020 | |
| Medtronic, INC. | $1,532.83 | 2021-2025 | Corevalve Evolut R, Onyx Frontier |
| Teleflex LLC | $165.74 | 2024 | Manta |
| W. L. Gore & Associates, INC. | $128.40 | 2025 | Gore Cardioform Septal Occluder |
| Pfizer INC. | $116.22 | 2020-2024 | |
| Philips North America LLC | $108.29 | 2024 | (Ao0) Igt Devices Intracardiac |
| Cardiva Medical, INC. | $36.40 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Novartis Pharmaceuticals Corporation | $28.52 | 2022-2024 | |
| Angiodynamics, INC. | $23.34 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $17.31 | 2023 | Orsiro Mission, Nhancer Rx, Recross |
| Biosense Webster, INC. | $14.43 | 2023 | Nuvision Ice Catheter |
| Cardiac Dimensions, INC. | $10.27 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.